title: Surface modification of strontium-doped porous bioactive ceramic scaffolds via poly(DOPA) coating and immobilizing silk fibroin for excellent angiogenic and osteogenic properties.
abstract: For bioceramic scaffolds employed in clinical applications, excellent bioactivity and tenacity were of great importance. Modifying inorganic SCPP scaffolds with biological macromolecules could obviously improve its bioactivity and eliminate its palpable brittleness. However, it was hard to execute directly due to extremely bad interfacial compatibility between them. In this research, dopamine (DOPA) was introduced onto strontium-doped calcium polyphosphate (SCPP) scaffolds, subsequently the preliminary material was successfully further modified by silk fibroin (SF). SCPP/D/SF possessed suitable biomechanical properties, ability to stimulate angiogenic factor secretion and excellent biocompatibility. Biomechanical examination demonstrated that SCPP/D/SF scaffolds yielded better compressive strength because of improved interfacial compatibility. MTT assay and CLSM observation showed that SCPP/D/SF scaffolds had good cytocompatibility and presented better inducing-cell-migration potential than pure SCPP scaffolds. Meanwhile, its ability to stimulate angiogenic factor secretion was measured through the ELISA assay and immunohistological analysis in vitro and in vivo respectively. The results revealed, superior to SCPP, SCPP/D/SF could effectively promote VEGF and bFGF expression, possibly leading to enhancing angiogenesis and osteogenesis. In a word, SCPP/D/SF could serve as a potential bone tissue engineering scaffold for comparable biomechanical properties and excellent bioactivity. It provided a novel idea for modification of inorganic materials to prepare promising bone tissue engineering scaffolds with the ability to accelerate bone regeneration and vascularization.
authors: College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, P.R. China. yuxixun@163.com.
authors: Xu
authors: X
authors: Wang
authors: Zhipeng
authors: Z
authors: Gu
authors: Bo
authors: B
authors: Jiang
authors: Li
authors: L
authors: Li
authors: Xixun
authors: X
authors: Yu
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000737:chemistry*; D001842:Bone and Bones / Q000737:chemistry* / Q000378:metabolism; D002130:Calcium Phosphates; D002516:Ceramics / Q000737:chemistry*; D019245:Compressive Strength / Q000502:physiology*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000737:chemistry; D004298:Dopamine / Q000737:chemistry* / Q000378:metabolism; D005349:Fibroins / Q000737:chemistry*; D007103:Immobilization; D010006:Osteoblasts / Q000737:chemistry* / Q000166:cytology / Q000502:physiology; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology*; D011108:Polymers / Q000737:chemistry*; D016062:Porosity; D013324:Strontium / Q000737:chemistry* / Q000378:metabolism; D013499:Surface Properties; D023822:Tissue Engineering / Q000295:instrumentation / Q000379:methods
chemical_list: D043925:Angiogenesis Inducing Agents; D002130:Calcium Phosphates; D011108:Polymers; C539838:poly(3,4-dihydroxyphenylalanine); D004295:Dihydroxyphenylalanine; D005349:Fibroins; D004298:Dopamine; D013324:Strontium